<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.1d1" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher">Problems of Social Hygiene, Public Health and History of Medicine</journal-id><journal-title-group><journal-title>Problems of Social Hygiene, Public Health and History of Medicine</journal-title></journal-title-group><issn publication-format="print">0869-866X</issn><issn publication-format="electronic">2412-2106</issn><publisher><publisher-name>Joint-Stock Company Chicot</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">367</article-id><article-id pub-id-type="doi">10.32687/0869-866X-2020-28-s1-778-784</article-id><article-categories><subj-group subj-group-type="heading"><subject>Научная статья</subject></subj-group></article-categories><title-group><article-title>Methods for quality of life assessment in children with orphanic diseases</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Makarova</surname><given-names>E. V.</given-names></name><bio></bio><email>rue-royal@inbox.ru</email><xref ref-type="aff" rid="aff-1"/><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Krysanov</surname><given-names>I. S.</given-names></name><bio></bio><email>-</email><xref ref-type="aff" rid="aff-1"/><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Vasilyeva</surname><given-names>T. P.</given-names></name><bio></bio><email>-</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Alexandrova</surname><given-names>O. Yu.</given-names></name><bio></bio><email>-</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Malachova</surname><given-names>A. R.</given-names></name><bio></bio><email>-</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff id="aff-1">N. A. Semashko National Research Institute of Public Health</aff><aff id="aff-2">FSBI “National Medical Research Center of Rehabilitation and Balneology” of the Ministry of Health of Russian Federation</aff><aff id="aff-3">FSBEI HE MGUPP Medical Institute of Continuing Education</aff><pub-date date-type="epub" iso-8601-date="2020-12-15" publication-format="electronic"><day>15</day><month>12</month><year>2020</year></pub-date><volume>28</volume><fpage>778</fpage><lpage>784</lpage><history><pub-date date-type="received" iso-8601-date="2021-04-06"><day>06</day><month>04</month><year>2021</year></pub-date></history><permissions><copyright-statement>Copyright © 2020,</copyright-statement><copyright-year>2020</copyright-year></permissions><abstract>Orphan (rare) diseases include congenital or acquired diseases, the frequency of occurrence of which does not exceed a certain number established by the laws of various countries. Despite its rarity, the orphan diseases make a significant contribution to the structure of population disability and most of them have no specific treatment. One of the main clinical challenges in these patients is to ensure their high quality of life (QOL). The review describes basic non-specific and specific questionnaires for assessing QOL in children with orphan diseases. An ideal questionnaire for assessing QOL in children with orphan disease should be sufficiently reliable, valid, sensitive and specific, fill out by a child or adolescents on their own, include questions covering as much as possible all areas of life and health aspects - especially those associated with the main decease. The questionnaire should not be too huge and complicated for the patient. From the side of the researcher, the simplicity of the tool in calculating and the ability to use the results for subsequent analysis are important.</abstract><kwd-group xml:lang="en"><kwd>orphan diseases</kwd><kwd>rare diseases</kwd><kwd>quality of life</kwd><kwd>personalized medicine</kwd><kwd>mental health</kwd><kwd>physical health</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>орфанные заболевания</kwd><kwd>редкие заболевания</kwd><kwd>качество жизни</kwd><kwd>персонализированная медицина</kwd><kwd>психическое здоровье</kwd><kwd>физическое здоровье</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>European Medicines Agency Annual report on the use of the special contribution for orphan medicinal products (2019). Режим доступа: https://www.ema.europa.eu/en/documents/annual-report/annual-report-use-special-contribution-orphan-medicinal-products-2019_en.pdf</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Pelentsov L. J., Laws T. A., Esterman A. J. The supportive care needs of parents caring for a child with a rare disease: a scoping review. Disabil. Health J. 2015;8:475-91. doi: 10.1016/j.dhjo.2015.03.009</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Orphanet Report Series - Prevalence of rare diseases: Bibliographic data. 2020 Jan;(1). Режим доступа: http://www.orpha.net/orphacom/cahiers/docs/GB/Prevalence_of_rare_diseases_by_alphabetical_list.pdf</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Волкова Н. С., Аксу Э. Редкие (орфанные) заболевания: правовое регулирование в России и за рубежом. Журнал зарубежного законодательства и сравнительного правоведения. 2018;4(71):154-60.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Shilling V., Morris C., Thompson-Coon J., Ukoumunne O., Rogers M., Logan S. Peer support for parents of children with chronic disabling conditions: a systematic review of quantitative and qualitative studies. Dev. Med. Child Neurol. 2013;55(7):602-9. doi: 10.1111/dmcn.12091</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Rath A., Salamon V., Peixoto S., et al. A systematic literature review of evidence-based clinical practice for rare diseases: what are the perceived and real barriers for improving the evidence and how can they be overcome? Trials. 2017;18(1):556. doi: 10.1186/s13063-017-2287-7</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>WHOQOL Group. The World Health Organization Quality of life assessment (WHOQOL): position paper from the World Health Organization. Soc. Sce. Med. 1995;41:1403-9.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Cohen J. S., Biesecker B. B., Quality of life in rare genetic conditions: a systematic review of the literature. Am. J. Med. Genet. Part A. 2010;152A(5):1136-56. doi: 10.1002/ajmg.a.33380</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Solovieva S., Santavirta N., Santavirta S., Konttinen Y. T. Assessing quality of life in individuals with hereditary blood coagulation disorders. Qual. Life Res. 2004;13:987-1000. PubMed: 1523351.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Grootenhuis M. A., de Boone J., van der Kooi A. J. Living with muscular dystrophy: Health related quality of life consequences for children and adults. Health Qual. Life Outcomes. 2007;5:31. PubMed: 17553127.</mixed-citation></ref></ref-list></back></article>
